Hodgkin Lymphoma Outcomes at KFSYSCC

Between 2013-2017, the five-year survival rate for Hodgkin Lymphoma at KFSYSCC was 88% vs 82% for other hospitals in Taiwan.

Basic Information and Distribution of 192 Hodgkin Lymphoma Patients at KFSYSCC from 1990-2019

  
    


    
    
    




    
            
            Total
            1990-1994
            1995-1999
            2000-2004
            2005-2009
            2010-2014
            2015-2019
        

    
            n
            192
            3 (2%)
            15 (8%)
            39 (20%)
            48 (25%)
            45 (23%)
            42 (22%)
        

            Gender (%)
        

            Male
            102 (53%)
            2 (67%)
            6 (40%)
            23 (59%)
            28 (58%)
            21 (47%)
            22 (52%)
        

            Female
            90 (47%)
            1 (33%)
            9 (60%)
            16 (41%)
            20 (42%)
            24 (53%)
            20 (48%)
        

            Age
        

            Mean/Median
            34/31
            25/30
            30/24
            35/32
            35/33
            33/28
            35/33
        

            Range
            5-86
            15-30
            15-74
            14-79
            5-75
            16-86
            15-69
        

            Q1-Q3
            23-40
            15-30
            21-35
            22-41
            24-41
            23-34
            27-43
        

            Stage (%)
        

            I
            14 (7%)
            0 (0%)
            2 (13%)
            6 (15%)
            1 (2%)
            2 (4%)
            3 (7%)
        

            II
            86 (45%)
            0 (0%)
            3 (20%)
            13 (33%)
            28 (58%)
            25 (56%)
            17 (40%)
        

            III
            29 (15%)
            1 (33%)
            0 (0%)
            3 (8%)
            6 (13%)
            10 (22%)
            9 (21%)
        

            IV
            33 (17%)
            0 (0%)
            1 (7%)
            5 (13%)
            6 (13%)
            8 (18%)
            13 (31%)
        

            Unknown
            30 (16%)
            2 (67%)
            9 (60%)
            12 (31%)
            7 (15%)
            0 (0%)
            0 (0%)
        






  

	Total	1990-1994	1995-1999	2000-2004	2005-2009	2010-2014	2015-2019
n	192	3 (2%)	15 (8%)	39 (20%)	48 (25%)	45 (23%)	42 (22%)
Gender (%)
Male	102 (53%)	2 (67%)	6 (40%)	23 (59%)	28 (58%)	21 (47%)	22 (52%)
Female	90 (47%)	1 (33%)	9 (60%)	16 (41%)	20 (42%)	24 (53%)	20 (48%)
Age
Mean/Median	34/31	25/30	30/24	35/32	35/33	33/28	35/33
Range	5-86	15-30	15-74	14-79	5-75	16-86	15-69
Q1-Q3	23-40	15-30	21-35	22-41	24-41	23-34	27-43
Stage (%)
I	14 (7%)	0 (0%)	2 (13%)	6 (15%)	1 (2%)	2 (4%)	3 (7%)
II	86 (45%)	0 (0%)	3 (20%)	13 (33%)	28 (58%)	25 (56%)	17 (40%)
III	29 (15%)	1 (33%)	0 (0%)	3 (8%)	6 (13%)	10 (22%)	9 (21%)
IV	33 (17%)	0 (0%)	1 (7%)	5 (13%)	6 (13%)	8 (18%)	13 (31%)
Unknown	30 (16%)	2 (67%)	9 (60%)	12 (31%)	7 (15%)	0 (0%)	0 (0%)

Based on KFSYSCC's cancer registry data from 1990 to 2019, there were a total of 192 analytic Hodgkin Lymphoma cases, comprising 102 males (53%) and 90 females (47%). The average and median ages were 34 and 31 years old, respectively, with the youngest patient being 5 years old and the oldest at 86 years old; the interquartile range (Q1-Q3) spanned 23-40 years. When examined by stage, 14 patients were stage I (7%), 86 were stage II (45%), 29 were stage III (15%), and 33 were stage IV (17%). The table below presents the basic patient information and stage distribution, categorized by the year of diagnosis.

Survival curves for Hodgkin lymphoma patients, showing probability of overall survival over years after diagnosis, stratified by diagnosis years from 1990 to 2019.

Survival Curves for 192 Hodgkin Lymphoma Patients (1990-2019), Stratified by Year of Diagnosis

From 1990 to 2019, the chart illustrates the five-year observed survival rates for 192 Hodgkin Lymphoma patients at KFSYSCC, stratified by the year of diagnosis. The graph shows the five-year survival rate for Hodgkin Lymphoma increased from 67% in 1990-1994 to 91% in 2015-2019, while the ten-year survival rate rose from 67% in 1990-1994 to 85% in 2010-2014.

Treatment Methods and Stages for 42 Hodgkin Lymphoma Patients at KFSYSCC (2015-2019)

  
    


    
    
    


    
    
        
            Treatment Type
            Total
            Stage I
            Stage II
            Stage III
            Stage IV
            Unknown
        

            Total
            42
            3
            17
            9
            13
            0
        

            Surgical Treatment
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
        

            Radiation Therapy
            25 (60%)
            3 (100%)
            12 (71%)
            4 (44%)
            6 (46%)
            0 (0%)
        

            Chemotherapy
            42 (100%)
            3 (100%)
            17 (100%)
            9 (100%)
            13 (100%)
            0 (0%)
        

            Targeted Therapy
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
        

            Hormone Therapy
            2 (5%)
            0 (0%)
            0 (0%)
            0 (0%)
            2 (15%)
            0 (0%)
        

            Immunotherapy
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
        

            Palliative Care
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
        

            Bone Marrow/Stem Cell Transplant
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
        

            No Record of Initial Treatment Reported
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
        





  

Treatment Type	Total	Stage I	Stage II	Stage III	Stage IV	Unknown
Total	42	3	17	9	13	0
Surgical Treatment	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)
Radiation Therapy	25 (60%)	3 (100%)	12 (71%)	4 (44%)	6 (46%)	0 (0%)
Chemotherapy	42 (100%)	3 (100%)	17 (100%)	9 (100%)	13 (100%)	0 (0%)
Targeted Therapy	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)
Hormone Therapy	2 (5%)	0 (0%)	0 (0%)	0 (0%)	2 (15%)	0 (0%)
Immunotherapy	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)
Palliative Care	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)
Bone Marrow/Stem Cell Transplant	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)
No Record of Initial Treatment Reported	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)

Between 2015 and 2019, there were a total of 42 analytic Hodgkin Lymphoma cases, including 3 patients in stage I, 17 in stage II, 9 in stage III, and 13 in stage IV. In terms of treatment methods, 25 patients (60%) received radiation therapy, 42 (100%) underwent chemotherapy, and 2 (5%) received hormone therapy.

A line graph showing five-year survival rates of 42 Hodgkin lymphoma patients. The x-axis is labeled 'Years after Diagnosis' from 0 to 10, and the y-axis is labeled 'Probability of Overall Survival.' Four lines represent different stages: Stage I, II, III, and IV, with Stage I and IV maintaining 100% survival, Stage II at 92%, and Stage III at 76%. A legend indicates sample sizes and 5-year survival percentages for each stage. The caption reads 'Figure 2-3-2: Five-Year Survival Rates of 42 Hodgkin Lymphoma Patients by Stage (2015-2019).'

Five-Year Survival Rates of 42 Hodgkin Lymphoma Patients by Stage (2015-2019)

KFSYSCC’s 2015-2019 five-year observed survival rates for 42 Hodgkin Lymphoma patients, stratified by stage, are presented in the following chart. As shown in the graph, the five-year survival rate is 100% for stage 1, 92% for stage 2, 76% for stage 3, and 100% for stage 4.